Clinical Trial Update: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Patients With Active Pemphigus Vulgaris (PV) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating mycophenolate mofetil (CellCept) with reduced corticosteroids in active pemphigus vulgaris; the study is completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus Vulgaris

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Corticosteroids (corticosteroids)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pemphigus Vulgaris (PV) | Phase 3 | Status: COMPLETED | Results posted: 2011-06-22